[Localized scleroderma in children and a therapeutic trial using calcitriol: a therapeutic possibility to define].
Bodemer
C
C
Amoric
J C
JC
Hamel-Teillac
D
D
De Prost
Y
Y
D002117:Calcitriol / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use* / Q000652:urine; D002118:Calcium / Q000652:urine; D002120:Calcium Channel Agonists / Q000008:administration & dosage / Q000627:therapeutic use*; D002130:Calcium Phosphates / Q000097:blood / Q000652:urine; D002648:Child; D005500:Follow-Up Studies; D006801:Humans; D012594:Scleroderma, Localized / Q000188:drug therapy*; D014807:Vitamin D / Q000031:analogs & derivatives / Q000097:blood / Q000652:urine
D002120:Calcium Channel Agonists; D002130:Calcium Phosphates; D014807:Vitamin D; C104450:25-hydroxyvitamin D; D002117:Calcitriol; D002118:Calcium